Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Oncostatin M Protein expressed in HEK-293T Cells - ABIN2039658
Yin, Chain: Suppression of lymphokine production in anti-minor histocompatibility antigen responses. in Cytokine 1991
Show all 3 Pubmed References
Human Oncostatin M Protein expressed in HEK-293T Cells - ABIN2039659
Godoy-Tundidor, Cavarretta, Fuchs, Fiechtl, Steiner, Friedbichler, Bartsch, Hobisch, Culig: Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase. in The Prostate 2005
Show all 3 Pubmed References
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN413690
Sen, Che, Rajamani, Zerboni, Sung, Ptacek, Arvin: Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. in Proceedings of the National Academy of Sciences of the United States of America 2012
Show all 2 Pubmed References
Human Oncostatin M Protein expressed in Escherichia coli (E. coli) - ABIN988184
Esmaeli, Allameh, Soleimani, Rahbarizadeh, Frouzandeh-Moghadam: The role of albumin and PPAR-? in differentiation-dependent change of fatty acid profile during differentiation of mesenchymal stem cells to hepatocyte-like cells. in Cell biochemistry and function 2014
Oncostatin M induces RIG-I (show DDX58 Proteins) and MDA5 (show IFIH1 Proteins) expression and enhances the double-stranded RNA response in fibroblasts.
The IL-6 (show IL6 Proteins)-type cytokine oncostatin M (OSM) indeed induces cellular properties associated with tumorigenesis and disease progression in non-transformed human prostate epithelial cells, including morphological changes, epithelial-to-mesenchymal transition (EMT (show ITK Proteins)), enhanced migration and pro-invasive growth patterns.
downregulation of miR (show MLXIP Proteins)-20a-5p is caused by promoter hypermethylation. MiR (show MLXIP Proteins)-20a-5p could also suppress the production of IL-17 (show IL17A Proteins) by targeting OSM and CCL1 (show CCL1 Proteins) production in CD4 (show CD4 Proteins)(+) T cells in patients with active VKH.
our findings suggested that OSM suppresses SLUG expression and tumor metastasis of lung adenocarcinoma cells through inducing the inhibitory effect of the STAT1 (show STAT1 Proteins)-dependent pathway and suppressing the activating effect of STAT3 (show STAT3 Proteins)-dependent signaling
Genistein (a specific Tyr (show TYR Proteins) phosphorylation inhibitor) leads to the interaction of CHOP (C/EBP Homologous Protein (show DDIT3 Proteins)) with C/EBP-beta (show CEBPB Proteins), thus negatively regulating it. Knockdown of C/EBP-beta (show CEBPB Proteins) also leads to inhibition of PMA-mediated OSM induction.
Data provide evidence that OSM regulates an epithelial-mesenchymal transition and cancer stem cell plasticity program that promotes tumorigenic properties in pancreatic cells.
OSM-induced plasticity was Signal Transducer and Activator of Transcription 3 (STAT3 (show STAT3 Proteins))-dependent, and also required a novel intersection with transforming growth factor-beta (TGF-beta)/SMAD (show SMAD1 Proteins) signaling. Removal of OSM or inhibition of STAT3 (show STAT3 Proteins) or SMAD3 (show SMAD3 Proteins) resulted in a marked reversion to a non-invasive, epithelial phenotype.
Neutrophils are a major source of OSM-producing cells in patients with chronic rhinosinusitis and severe asthma.
OSM and OSMR are highly expres (show TNF Proteins)sed in inflammatory bowel disease intestinal mucosa compared to control mucosa. OSM promotes inflammatory behavior in human intestinal stroma.
Study showed that in atrial fibrillation (AF) with thrombus, the atrial tissue infiltration of M1 macrophages increased significantly; the OSM expression was also found to increase simultaneously; downstream tissue factor (show F3 Proteins) (TF) increased and tissue factor (show F3 Proteins) pathway inhibitors (TFPI (show TFPI Proteins))decreased, leading to an imbalance between TF and TFPI (show TFPI Proteins) eventually. OSM might be related to thrombosis in patients with AF mediated by TF and TFPI (show TFPI Proteins)
OSM mitigated the proliferation of Th17 cells and decreased the expression of IL-17 (show IL17A Proteins) and IL-21 (show IL21 Proteins); it promoted the activation of suppressor of cytokine signaling 3 (SOCS3 (show SOCS3 Proteins)), STAT3 (show STAT3 Proteins), and STAT5 (show STAT5A Proteins); observations suggest that OSM can inhibit Th17 differentiation by reciprocally controlling SOCS3 (show SOCS3 Proteins), STAT3 (show STAT3 Proteins), and STAT5 (show STAT5A Proteins)
In an animal model of anti-TNF (show TNF Proteins)-resistant intestinal inflammation, genetic deletion or pharmacological blockade of OSM significantly attenuates colitis.
these results support the proinflammatory role of OSM when it is overexpressed in the skin. However, OSM expression was not required in the murine model of psoriasis induced by topical application of imiquimod, as demonstrated by the inflammatory phenotype of OSM-deficient mice or wild-type mice treated with anti-OSM antibodies.
OSM (mOSM) signals mainly via an OSM receptor (OSMR)-gp130 heterodimer and binds with only very low affinity to mLIFR.
Loss of Oncostatin M Signaling in Adipocytes Induces Insulin (show INS Proteins) Resistance and Adipose Tissue Inflammation in Vivo.
mechanism of OSM-induced cardiomyocyte dedifferentiation is associated with B-Raf (show SNRPE Proteins)/Mek (show MDK Proteins)/Erk (show EPHB2 Proteins) signaling pathway through the OSM receptor Obeta
Oncostatin M and interleukin-31 (show IL31 Proteins): Cytokines, receptors, signal transduction and physiology.
OSM plays multiple critical roles in the maintenance and development of the hematopoietic microenvironment in the bone marrow at a steady state as well as after injury.
OSM treatment preserved cardiac function, inhibited apoptosis and fibrosis, and stimulated angiogenesis via upregulating VEGF (show VEGFA Proteins) and bFGF (show FGF2 Proteins) in infarct border zone of ischemic myocardium, indicating that OSM could be a novel therapeutic target for MI.
The mechanism of Oncostatin M on cardiac ischemia/reperfusion injury is partly mediated by the Notch3 (show NOTCH3 Proteins)/Akt (show AKT1 Proteins) pathway.
Protein kinase R plays a pivotal role in oncostatin M and interleukin-1 signalling in bovine articular cartilage chondrocytes.
Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. This gene encodes a growth regulator which inhibits the proliferation of a number of tumor cell lines. It regulates cytokine production, including IL-6, G-CSF and GM-CSF from endothelial cells.